NexGen LPS-Flex Mobile and LPS-Mobile Bearing Knee System
Zimmer, Inc. · Decision date Sep 24, 2026
What did the FDA decide?
The FDA recorded decision OK30 on 2026-09-24 for P060037/S099, a 30-Day Notice submitted by Zimmer, Inc. for the NexGen LPS-Flex Mobile and LPS-Mobile Bearing Knee System. The notice covers a manufacturing process change: introduction of an Elma 3-Stage Parts Washer for the system's femoral components at the Zimmer facility in Warsaw, Indiana. The supplement reason is listed as a process change affecting manufacturer, sterilizer, packager or supplier.
This action concerns a supplement to an existing premarket approval rather than a new approval of the knee system. The device category is a semi-constrained, metal/polymer, mobile-bearing patellofemoral-tibial knee prosthesis under product code NJL, in the orthopedic specialty. The source record contains no documents, so the notice's technical content, cleaning validation data and any conditions attached to the decision are not available here and remain unknown.
Whether the parts-washer change alters residue limits, cleaning validation expectations or other manufacturing controls cannot be determined from the available fields, and no clinical or legal conclusion is drawn.
FDA approval order statement
introduction of Elma 3-Stage Parts Washer for the femoral components of the NexGen LPS-Flex Mobile and LPS-Mobile Bearing Knee System at the Zimmer Inc. facility in Warsaw, Indiana
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Orthopedic
- Decision date
- Sep 24, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P060037/S099
- Regulatory pathway
- PMA supplement
- Applicant
- Zimmer, Inc.
- Product code
- NJL
- Decision code
- OK30
- Decision date
- Sep 24, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Prosthesis, knee, patellofemorotibial, semi-constrained, metal/polymer, mobile bearing.
- Applicant
- Zimmer, Inc.
- Product code
- NJL
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P060037. Subsequent supplements may change the device or its indications.
FDA decision timeline
P060037 · Original PMA
NEXGEN LPS-FLEX MOBILE AND LPS-MOBILE BEARING KNEE SYSTEM
P060037/S099 received
Application receipt date recorded by FDA.
P060037/S099 · FDA decision
30-Day Notice
P060037/S100 · Related supplement
NexGen LPS-Flex/LPS Mobile Bearing Knee System
Timeline entries are records held by MedtechLedger for P060037. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P060037
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Zimmer, Inc. | PMA approval | Dec 10, 2007 | FDA | |
NexGen LPS-Flex/LPS Mobile Bearing Knee SystemP060037/S100 | Zimmer, Inc. | PMA supplement | Oct 16, 2026 | FDA |
Explore the linked device profile
Other records with product code NJL
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
LCS Knee SystemP830055/S378 | Depuy, Inc. | PMA supplement | Oct 27, 2026 | FDA |
| Depuy, Inc. | PMA supplement | Oct 27, 2026 | FDA | |
ATTUNE Revision Knee SystemP830055/S379 | Depuy, Inc. | PMA supplement | Oct 9, 2026 | FDA |
| Depuy, Inc. | PMA supplement | Oct 8, 2026 | FDA | |
LCS Total Knee SystemP830055/S380 | Depuy, Inc. | PMA supplement | Oct 5, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Zimmer, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- P.O. Box 708, Warsaw, IN, 46581
Sources and methodology
- Original FDA record: P060037/S099
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records



